The role of Rasayana therapy in management of chemotherapy induced side effects
Not Applicable
- Conditions
- Health Condition 1: T451- Poisoning by, adverse effect of and underdosing of antineoplastic and immunosuppressive drugs
- Registration Number
- CTRI/2021/05/033866
- Lead Sponsor
- Rasayu Cancer Clinic Pune
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1 Biopsy confirmed Diagnosed cases of carcinoma at any stage
2 Have taken at least three cycle of Chemotherapy without Rasayana therapy and willing to take further cycles with Rasayana therapy or
3 Patients have completed chemotherapy earlier and now willing to take chemotherapy and Rasayana therapy simultaneously
4 Patient who are Advised to take same chemotherapy along with Rasayana
5 Patients with intact cognitive functions who can recollect the intensity of adverse events or earlier chemotherapy
6 Patients who have planned to Take CT cycle at least 15 days after initiation of Rasayana therapy
Exclusion Criteria
Exclusion criteria
1.Patients taking radiotherapy
2. Patients taking another alternative therapy
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method